Cabasag, Jonelyn L.
HRN: 25-35-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2024
CEFUROXIME 750MG (VIAL)
06/30/2024
07/07/2024
IVTT
750mg
Q12H
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes